Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NVS-PAK1-1 是一种有效的选择性变构 PAK1 抑制剂,IC50值为5 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 363 | 现货 | ||
5 mg | ¥ 913 | 现货 | ||
10 mg | ¥ 1,450 | 现货 | ||
25 mg | ¥ 2,970 | 现货 | ||
50 mg | ¥ 4,390 | 现货 | ||
100 mg | ¥ 6,290 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 956 | 现货 |
产品描述 | NVS-PAK1-1 is an effective and selective allosteric PAK1 inhibitor (IC50: 5 nM). |
靶点活性 | PAK1:5 nM |
体外活性 | NVS-PAK1-1 inhibits the proliferation of the Su86.86 cell line only above a concentration of 2 μM, consistent with the observation. NVS-PAK1-1 (6-20 μM) inhibits the phosphorylation of the downstream substrate MEK1 Ser289. Inhibition of downstream signaling, by applying a mixture of NVS-PAK1-1 and PAK2 shRNA, and cell proliferation at a significantly lower 0.21 μM concentration is achieved. NVS-PAK1-1 shows high selectivity for inhibition of PAK1 over other PAK isoforms and the kinome in general. NVS-PAK1-1 has a biochemical PAK1 Kd of 7 nM and a PAK2 Kd of 400 nM. NVS-PAK1-1 displays excellent activity in biochemical assays and an exceptional selectivity profile against other known kinases . |
体内活性 | NVS-PAK1-1 displays relatively poor stability in rat liver microsomes (RLM). This would limit its application for in vivo studies (t1/2 in RLM 3.5 min). |
分子量 | 479.93 |
分子式 | C23H25ClF3N5O |
CAS No. | 1783816-74-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (260.45 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.0836 mL | 10.4182 mL | 20.8364 mL | 52.0909 mL |
5 mM | 0.4167 mL | 2.0836 mL | 4.1673 mL | 10.4182 mL | |
10 mM | 0.2084 mL | 1.0418 mL | 2.0836 mL | 5.2091 mL | |
20 mM | 0.1042 mL | 0.5209 mL | 1.0418 mL | 2.6045 mL | |
50 mM | 0.0417 mL | 0.2084 mL | 0.4167 mL | 1.0418 mL | |
100 mM | 0.0208 mL | 0.1042 mL | 0.2084 mL | 0.5209 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
NVS-PAK1-1 1783816-74-9 Cytoskeletal Signaling PAK Inhibitor p21 activated kinases NVS PAK1 1 inhibit NVS-PAK-1-1 NVSPAK11 inhibitor